Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cingulate wants to be the next Eli Lilly — and stay in Kansas City By: Kansas City Business Journal via Business Journals May 19, 2022 at 15:15 PM EDT Cingulate, which went public last year, developed an innovative drug-delivery platform that could be game-changing for patients dealing with conditions such as ADHD and anxiety. CEO Shane Schaffer sees its application extending to other conditions. Read More >> Related Stocks: Harbor Disruptive Innovation ETF Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Cingulate wants to be the next Eli Lilly — and stay in Kansas City By: Kansas City Business Journal via Business Journals May 19, 2022 at 15:15 PM EDT Cingulate, which went public last year, developed an innovative drug-delivery platform that could be game-changing for patients dealing with conditions such as ADHD and anxiety. CEO Shane Schaffer sees its application extending to other conditions. Read More >> Related Stocks: Harbor Disruptive Innovation ETF